Feedback / Questions
FYB201 (ranibizumab biosimilar) - Amneal, Formycon, Coherus
https://www.globenewswire.com/news-release/2021/02/24/2181817/0/en/Coherus-BioSciences-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-Results.html#:~:text=Coherus%20had%20cash%20and%20cash,share%20on%20a%20diluted%20basis.
Feb 24, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next